18.1 C
Delhi
Friday, January 16, 2026

Tag: obesity drugs

Novo Nordisk Q3 Profit Falls 27%, Cuts 9,000 Jobs Amid Restructuring

Ozempic maker Novo Nordisk reports declining profits, job cuts and lowered outlook amid increasing competition in obesity drug market.